No significant long-term complications from inadvertent exposure to gonadotropin-releasing hormone agonist during early pregnancy in mothers and offspring: a retrospective analysis

BACKGROUND: Administration of gonadotropin-releasing hormone agonist (GnRH-a) in the luteal phase is commonly used for pituitary suppression during in vitro fertilisation (IVF). There is an ineluctable risk of inadvertent exposure of spontaneous pregnancy to GnRH-a. However, little is known about th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Huan, Xu, Xiaoyan, Ma, Cong, Zhou, Yiran, Pei, Shanai, Geng, Hao, He, Ye, Xu, Qianhua, Xu, Yuping, He, Xiaojin, Zhou, Ping, Wei, Zhaolian, Xu, Xiaofeng, Cao, Yunxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980339/
https://www.ncbi.nlm.nih.gov/pubmed/33743741
http://dx.doi.org/10.1186/s12958-021-00732-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980339/
https://www.ncbi.nlm.nih.gov/pubmed/33743741
http://dx.doi.org/10.1186/s12958-021-00732-1

Ejemplares similares